SpyGlass Pharma, Inc. Common Stock
Support and Resistance Levels
Past performance
News About SGP
All events for SGP
All deals for SGP
Financial Ratios
Financial Statements
SGP vs Sector & Peers
About SpyGlass Pharma, Inc. Common Stock
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA. Website spyglasspharma.com
Headquarters Aliso Viejo, CA, US